Molecular surveillance for drug-resistant Plasmodium falciparum malaria in Malawi

Acta Tropica

Volumn 102, Issue 2, 2007, Pages 138-142

  Nkhoma, Standwell ^a,b   Molyneux, Malcolm ^a   Ward, Stephen ^b  

^a UNIVERSITY OF MALAWI   (Malawi)

^b LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

Antimalarial drug resistance; Chloroquine; Malawi; Plasmodium falciparum; Sulphadoxine pyrimethamine

Indexed keywords

CHLOROQUINE; DIHYDROFOLATE REDUCTASE; DIHYDROPTEROATE SYNTHASE; FANSIDAR;

ANTIMALARIAL AGENT; DRUG RESISTANCE; MALARIA; MOLECULAR ANALYSIS; MUTATION; PROTOZOAN; SURVEILLANCE AND ENFORCEMENT;

ARTICLE; CONTROLLED STUDY; GEOGRAPHY; HUMAN; INFECTION RATE; MALARIA; MALAWI; MOLECULAR BIOLOGY; PLASMODIUM FALCIPARUM; POINT MUTATION;

ANIMALS; ANTIMALARIALS; CHLOROQUINE; DIHYDROPTEROATE SYNTHASE; DNA, PROTOZOAN; DRUG COMBINATIONS; DRUG RESISTANCE; HUMANS; MALARIA, FALCIPARUM; MALAWI; MEMBRANE TRANSPORT PROTEINS; PLASMODIUM FALCIPARUM; POINT MUTATION; PROTOZOAN PROTEINS; PYRIMETHAMINE; SEQUENCE ANALYSIS, DNA; SULFADOXINE; TETRAHYDROFOLATE DEHYDROGENASE;

AFRICA; EAST AFRICA; MALAWI; SUB-SAHARAN AFRICA;

PLASMODIUM FALCIPARUM;

EID: 34250178810     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actatropica.2007.04.006     Document Type: Article

References (30)

1. Alker A.P., Mwapasa V., Purfield A., Rogerson S.J., Molyneux M.E., Kamwendo D.D., Tadesse E., Chaluluka E., and Meshnick S.R. Mutations associated with sulfadoxine-pyrimethamine and chlorproguanil resistance in Plasmodium falciparum isolates from Blantyre. Antimicrob. Agents. Chemother. 49 (2005) 3919-3921
2. Brooks D.R., Wang P., Read M., Watkins W.M., Sims P.F., and Hyde J.E. Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine. Eur. J. Biochem. 224 (1994) 397-405
3. Cowman A.F., Morry M.J., Biggs B.A., Cross G.A., and Foote S.J. Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 9109-9113
4. Curtis J., Maxwell C.A., Msuya F.H., Mkongewa S., Alloueche A., and Warhurst D.C. Mutations in dhfr in Plasmodium falciparum infections selected by chlorproguanil-dapsone treatment. J. Infect. Dis. 186 (2002) 1861-1864
5. Djimdé A., Doumbo O.K., Cortese J.F., Kayentao K., Doumbo S., Diourte Y., Dicko A., Su X., Nomura T., Fidock D.A., Wellems T.E., and Plowe C.V. A molecular marker for chloroquine-resistant falciparum malaria. N. Engl. J. Med. 344 (2001) 257-263
6. Djimdé A., Doumbo O.K., Steketee R.W., and Plowe C.V. Application of a molecular marker for surveillance of chloroquine-resistant falciparum malaria. Lancet 358 (2001) 890-891
7. Djimdé A.A., Doumbo O.K., Traore O., Guindo A.B., Kayentao K., Diourte Y., Niare-Doumbo S., Coulibaly D., Kone A.K., Cissoko Y., Tekete M., Fofana B., Dicko A., Diallo D.A., Wellems T.E., Kwiatkowski D., and Plowe C.V. Clearance of drug-resistant parasites as a model for protective immunity in Plasmodium falciparum malaria. Am. J. Trop. Med. Hyg. 69 (2003) 558-563
8. Dorsey G., Kamya M.R., Singh A., and Rosenthal P.J. Polymorphisms in the Plasmodium falciparum pfcrt and pfmdr-1 genes and clinical response to chloroquine in Kampala, Uganda. J. Infect. Dis. 183 (2001) 1417-1420
9. Fidock D.A., Nomura T., Talley A.K., Cooper R.A., Dzekunov S.M., Ferdig M.T., Ursos L.M.B., Sidhu A., Naude B., Deitsch K.W., Su X., Wootton J.C., Roepe P.D., and Wellems T.E. Mutations in the P. falciparum digestive vacuole transmembrane protein pfcrt and evidence for their role in chloroquine resistance. Mol. Cell. 6 (2000) 861-871
10. Foote S.J., Galatis D., and Cowman A.F. Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 3014-3017
11. Foote S.J., and Cowman A.F. The mode of action and the mechanism of resistance to antimalarial drugs. Acta. Trop. 56 (1994) 157-171
12. International Artemisinin Study Group, 2004. Artesunate combinations for treatment of malaria: meta-analysis. Lancet 363, 9-17.
13. Kublin J.G., Witzig R.S., Shankar A.H., Zurita J.Q., Gilman R.H., Guarda J.A., Cortese J.F., and Plowe C.V. Molecular assays for surveillance of antifolate-resistant malaria. Lancet 351 (1998) 1629-1630
14. Kublin J.G., Dzinjalamala F.K., Kamwendo D.D., Malkin E.M., Cortese J.F., Martino L.M., Mukadam R.A., Rogerson S.J., Lescano A.G., Molyneux M.E., Winstanley P.A., Chimpeni P., Taylor T.E., and Plowe C.V. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. J. Infect. Dis. 185 (2002) 380-388
15. Kublin J.G., Cortese J.F., Njunju E.M., Mukadam R.A.G., Wirima J.J., Kazembe P.N., Djimdé A.A., Kouriba B., Taylor T.E., and Plowe C.V. Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. J. Infect. Dis. 187 (2003) 1870-1875
16. Laufer M.K., Thesing P.C., Eddington N.D., Masonga R., Dzinjalamala F.K., Takala S.L., Taylor T.E., and Plowe C.V. Return of chloroquine antimalarial efficacy in Malawi. N. Engl. J. Med. 355 (2006) 1959-1966
17. Mayor A.G., Gomez-Olive X., Aponte J.J., Casimiro S., Mabunda S., Dgedge M., Barreto A., and Alonso P.L. Prevalence of the K76T mutation in the putative Plasmodium falciparum chloroquine resistance transporter (pfcrt) gene and its relation to chloroquine resistance in Mozambique. J. Infect. Dis. 183 (2001) 1413-1416
18. Nzila A.M., Mberu E.K., Sulo J., Dayo H., Winstanley P.A., Sibley C.H., and Watkins W.M. Towards an understanding of the mechanism of pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: genotyping of dihydrofolate reductase and dihydropteroate synthase of Kenyan parasites. Antimicrob. Agents. Chemother. 44 (2000) 991-996
19. Ochong E., Nzila A., Kimani S., Kokwaro G., Mutabingwa T., Watkins W., and Marsh K. Molecular monitoring of the Leu-164 mutation of dihydrofolate reductase in a highly sulfadoxine/pyrimethamine-resistant area in Africa. Malar J. 2 (2003) 46
20. Peterson D.S., Walliker D., and Wellems T.E. Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 9114-9118
21. Plowe C.V., Djimdé A., Bouare M., Doumbo O., and Wellems T.E. Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. Am. J. Trop. Med. Hyg. 52 (1995) 565-568
22. Plowe C.V., Cortese J.F., Djimdé A., Nwanyanwu O.C., Watkins W.M., Winstanley P.A., Estrada-Franco J.G., Mollinedo R.E., Avila J.C., Cespedes J.L., Carter D., and Doumbo O.K. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance. J. Infect. Dis. 176 (1997) 1590-1596
23. Plowe C.V., Kublin J.G., Dzinjalamala F.K., Kamwendo D.S., Mukadam R.A.G., Chimpeni P., Molyneux M.E., and Taylor T.E. Sustained clinical efficacy of sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Malawi after 10 years as first line treatment: five year prospective study. BMJ 328 (2004) 545-548
24. Sibley C.H., Hyde J.E., Sims P.F., Plowe C.V., Kublin J.G., Mberu E.K., Cowman A.F., Winstanley P.A., Watkins W.M., and Nzila A.M. Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next?. Trends Parasitol. 17 (2001) 582-588
25. Sidhu A.B.S., Verdier-Pinard D., and Fidock D.A. Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations. Science 298 (2002) 210-213
26. Staedke S.G., Sendagire H., Lamola S., Kamya M.R., Dorsey G., and Rosenthal P. Relationship between age, molecular markers, and response to sulphadoxine-pyrimethamine treatment in Kampala, Uganda. Trop. Med. Int. Health 9 (2004) 624-629
27. Wang P., Lee C.S., Bayoumi R., Djimdé A., Doumbo O., Swedberg G., Dao L.D., Mshinda H., Tanner M., Watkins W.M., Sims P.F., and Hyde J.E. Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins. Mol. Biochem. Parasitol. 89 (1997) 161-177
28. Wang P., Read M., Sims P.F., and Hyde J.E. Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization. Mol. Microbiol. 23 (1997) 979-986
29. Watkins W.M., Mberu E.K., Winstanley P.A., and Plowe C.V. The efficacy of antifolate antimalarial combinations in Africa: a predictive model based on pharmacodynamic and pharmacokinetic analyses. Parasitol. Today 13 (1997) 459-464
30. World Health Organization 2003. Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria. WHO/HTM/RBM/2003.50.